- Home
- USCB vs VSTM Comparison
USCB vs VSTM Comparison
Compare USCB & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USCB
- VSTM
- Stock Information
- Founded
- USCB 2002
- VSTM 2010
- Country
- USCB United States
- VSTM United States
- Employees
- USCB N/A
- VSTM N/A
- Industry
- USCB Major Banks
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- USCB Finance
- VSTM Health Care
- Exchange
- USCB Nasdaq
- VSTM Nasdaq
- Market Cap
- USCB 366.2M
- VSTM 313.1M
- IPO Year
- USCB 2021
- VSTM 2012
- Fundamental
- Price
- USCB $18.56
- VSTM $6.08
- Analyst Decision
- USCB Buy
- VSTM Strong Buy
- Analyst Count
- USCB 2
- VSTM 8
- Target Price
- USCB $18.25
- VSTM $13.00
- AVG Volume (30 Days)
- USCB 39.0K
- VSTM 988.6K
- Earning Date
- USCB 04-24-2025
- VSTM 03-20-2025
- Dividend Yield
- USCB 1.36%
- VSTM N/A
- EPS Growth
- USCB 47.62
- VSTM N/A
- EPS
- USCB 1.24
- VSTM N/A
- Revenue
- USCB $79,519,000.00
- VSTM $10,000,000.00
- Revenue This Year
- USCB $22.51
- VSTM N/A
- Revenue Next Year
- USCB $7.69
- VSTM $867.23
- P/E Ratio
- USCB $15.05
- VSTM N/A
- Revenue Growth
- USCB 25.02
- VSTM N/A
- 52 Week Low
- USCB $10.25
- VSTM $2.10
- 52 Week High
- USCB $21.86
- VSTM $13.52
- Technical
- Relative Strength Index (RSI)
- USCB 47.76
- VSTM 42.16
- Support Level
- USCB $18.40
- VSTM $6.01
- Resistance Level
- USCB $19.25
- VSTM $6.89
- Average True Range (ATR)
- USCB 0.49
- VSTM 0.47
- MACD
- USCB 0.03
- VSTM -0.14
- Stochastic Oscillator
- USCB 51.26
- VSTM 11.83
About USCB USCB Financial Holdings Inc.
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.